Jaguar Health JAGX
NASDAQ JAGX
$0.48 +0.05 (+10.46%)
At close: Nov 11, 2026 · 4:00 PM EST

Jaguar Health (JAGX) Return on Sales [ROS] (2015 - 2026)

Updated

Jaguar Health's Return on Sales [ROS] was -620.16% in Q2 2026, down 351.38 percentage points from -268.78% a year earlier and down 670.39 percentage points from the prior quarter.

Analysis

Jaguar Health (JAGX) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jaguar Health's Return on Sales [ROS] was -93.10% through Jun 30, 2026, up 185.03 percentage points year-over-year; for FY2025, it came in at -398.82%, down 135.06 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -114.89 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -263.76% in FY2024 (+87.55 pp), -351.31% in FY2023 (-63.46 pp), -287.85% in FY2022 (+651.21 pp) and -939.05% in FY2021 (-655.12 pp).
  • Quarterly Return on Sales [ROS] has moved between -1512.54% (Q3 2021) and 50.23% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of -25.81 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2022 (a gain of 2785.98 percentage points); the worst was Q3 2021 (a drop of 1318.71 percentage points).
  • Per Business Quant data, JAGX's Return on Sales [ROS] in the three quarters before Q2 2026 was 50.23% (Q1 2026), -656.63% (Q4 2025) and -234.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Jaguar Health 70,422.88 -17.18 Mn 194,000.00 -620.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -620.16%
Mar 31, 2026 50.23%
Dec 31, 2025 -656.63%
Sep 30, 2025 -234.77%
Jun 30, 2025 -268.78%
Mar 31, 2025 -425.52%
Dec 31, 2024 -232.46%
Sep 30, 2024 -233.66%
Jun 30, 2024 -264.50%
Mar 31, 2024 -349.43%
Dec 31, 2023 -328.57%
Sep 30, 2023 -312.37%
Jun 30, 2023 -302.77%
Mar 31, 2023 -499.24%
Dec 31, 2022 -192.82%
Sep 30, 2022 -314.16%
Jun 30, 2022 -221.81%
Mar 31, 2022 -447.77%
Dec 31, 2021 -520.29%
Sep 30, 2021 -1,512.54%
API Access

Jaguar Health Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=JAGX&period=max&api_key=YOUR_API_KEY